AU2002365189A1 - P85-alpha nucleic acids, polypeptides and related methods - Google Patents
P85-alpha nucleic acids, polypeptides and related methodsInfo
- Publication number
- AU2002365189A1 AU2002365189A1 AU2002365189A AU2002365189A AU2002365189A1 AU 2002365189 A1 AU2002365189 A1 AU 2002365189A1 AU 2002365189 A AU2002365189 A AU 2002365189A AU 2002365189 A AU2002365189 A AU 2002365189A AU 2002365189 A1 AU2002365189 A1 AU 2002365189A1
- Authority
- AU
- Australia
- Prior art keywords
- polypeptides
- nucleic acids
- related methods
- alpha nucleic
- alpha
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000039446 nucleic acids Human genes 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70585—CD44
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
- G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
- G01N2333/16—HIV-1, HIV-2
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70585—CD44
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34588501P | 2001-11-09 | 2001-11-09 | |
US60/345,885 | 2001-11-09 | ||
PCT/US2002/035989 WO2003060067A2 (fr) | 2001-11-09 | 2002-11-08 | Acides nucleiques et polypeptides p85-alpha, et procedes associes |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2002365189A1 true AU2002365189A1 (en) | 2003-07-30 |
AU2002365189A8 AU2002365189A8 (en) | 2003-07-30 |
Family
ID=23356927
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002365189A Abandoned AU2002365189A1 (en) | 2001-11-09 | 2002-11-08 | P85-alpha nucleic acids, polypeptides and related methods |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2002365189A1 (fr) |
IL (1) | IL161765A0 (fr) |
WO (1) | WO2003060067A2 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004017950A2 (fr) * | 2002-08-22 | 2004-03-04 | Piramed Limited | Inhibiteurs de phosphatidylinositol 3,5-biphosphate en tant qu'agents antiviraux |
US20120039905A1 (en) * | 2009-01-13 | 2012-02-16 | The Babraham Institute | The Role of p110 delta Signaling in Morbidity and Lung Pathology Induced by Influenza Virus Infection |
US10123991B2 (en) * | 2015-05-15 | 2018-11-13 | Global Biolife Inc. | Electrophilically enhanced phenolic compounds for treating inflammatory related diseases and disorders |
US10966954B2 (en) | 2016-05-16 | 2021-04-06 | Global Biolife Inc. | Electrophilically enhanced phenolic compounds for treating inflammatory related diseases and disorders |
WO2018085208A1 (fr) | 2016-11-02 | 2018-05-11 | The Research Foundation For The State University Of New York | Procédés d'inhibition de virus à l'aide de compositions ciblant l'interaction tsg101-ubiquitine |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6537972B1 (en) * | 1997-06-02 | 2003-03-25 | Subsidiary No. 3., Inc. | Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
-
2002
- 2002-11-08 AU AU2002365189A patent/AU2002365189A1/en not_active Abandoned
- 2002-11-08 IL IL16176502A patent/IL161765A0/xx unknown
- 2002-11-08 WO PCT/US2002/035989 patent/WO2003060067A2/fr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2003060067A2 (fr) | 2003-07-24 |
WO2003060067A3 (fr) | 2004-07-29 |
IL161765A0 (en) | 2005-11-20 |
AU2002365189A8 (en) | 2003-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002366951A1 (en) | Novel nucleic acids and polypeptides | |
AU2002326877A1 (en) | Novel nucleic acids and polypeptides | |
AU2002314709A1 (en) | Novel nucleic acids and polypeptides | |
AU2001249251A1 (en) | Novel nucleic acids and polypeptides | |
AU2001243142A1 (en) | Novel nucleic acids and polypeptides | |
AU2001234944A1 (en) | Novel nucleic acids and polypeptides | |
AU2001290548A1 (en) | Novel nucleic acids and polypeptides | |
AU2001245280A1 (en) | Novel nucleic acids and polypeptides | |
AU2001233041A1 (en) | Novel nucleic acids and polypeptides | |
AU2001238347A1 (en) | Novel nucleic acids and polypeptides | |
AU2001296235A1 (en) | Novel nucleic acids and polypeptides | |
AU2001263006A1 (en) | Novel nucleic acids and polypeptides | |
AU2002343417A1 (en) | Novel nucleic acids and polypeptides | |
AU2002246502A1 (en) | Nucleic acids and polypeptides | |
AU2001233017A1 (en) | Novel nucleic acids and polypeptides | |
AU2001241511A1 (en) | Novel nucleic acids and polypeptides | |
AU2001292561A1 (en) | Nucleic acids and polypeptides | |
AU2001250872A1 (en) | Novel nucleic acids and polypeptides | |
AU8146601A (en) | AKT nucleic acids, polypeptides, and uses thereof | |
WO2002016439A8 (fr) | Nouveaux acides nucleiques et polypeptides | |
AU2002365189A1 (en) | P85-alpha nucleic acids, polypeptides and related methods | |
AU2003234274A1 (en) | D1-1 nucleic acids, polypeptides and related methods | |
AU2002250419A1 (en) | Novel nucleic acids and polypeptides | |
AU2002250254A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001263005A1 (en) | Novel nucleic acids and polypeptides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |